Illumina Launches Cancer Kit
Illumina introduces whole-genome sequencing kit for cancer research, potentially aiding in disease diagnosis and treatment. This may impact biotech stocks.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.